In this interview, StockBox spoke to Jason Drummond, CEO at MedPal AI (AIM: MPAL) about launching a 24/7 robotic prescription center, combining AI with automation to revolutionise healthcare access.
The economic case for medicinal cannabis
In the last few years, it has become increasingly evident that medicinal cannabis is not only revolutionising the way we manage specific health issues, it’s also quietly transforming the economic
Emerging Small Cap Investment Opportunities
Small-cap stocks represent some of the more appealing opportunities for investors who enjoy diversifying their portfolios and capitalizing on high growth potential. The typical small-cap company, within the valuation bracket
Ondine Biomedical (LON:OBI) King’s College Hospital to run Steriwave pilot
Ondine Biomedical Inc. (LON: OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments, confirms that King’s College Hospital (KCH) will be running a pilot of its Steriwave® light-activated antimicrobial technology.
Nursing Ethics: Managing Moral Dilemmas in Patient Care
Are you a nurse, or are you considering becoming a nurse, via accelerated nursing programs online? It’s a noble career to pursue, a highly-regarded profession and can be a stable,
eEnergy shares surge 40% following a £1.75 million investment from Luceco
Shares of eEnergy PLC (AIM: EAAS) experienced a significant increase of over 40% following the acquisition of its shares by Luceco PLC (LSE: LUCE), a provider of LED lighting, for
Futura Medical PLC (AIM:FUM) MED3000 Granted US FDA Approval for OTC Sale
Futura’s Fast-Acting Topical Gel for the Treatment of Erectile Dysfunction Granted Marketing Authorisation by the US FDA for Over-the-Counter Sale
Byotrol PLC – US EPA approves Byotrol24 as long-lasting virucide
Byotrol Plc (AIM: BYOT), a company specializing in infection prevention and control, is thrilled to announce that its unique 24-hour germ-killing surface sanitiser, Byotrol 24 (EPA Reg. Number 83614-1), has
DeepMatter Group PLC (AIM:DMTR) DeepMatter signs multi-year license agreement with the Life Science business sector of Merck
DeepMatter Group Plc (AIM: DMTR, “Deepmatter”, the “Group”), the digital chemistry data and software company, has signed a multiyear database license agreement with Merck, a leading science and technology company,
Futura Medical PLC (AIM:FUM) Highly positive FM71 Phase 3 Study Results
Highly positive FM71 Phase 3 Study Results with all primary and secondary endpoints achieved, MED3000 remains on track to obtain US FDA marketing authorisation
Futura Medical PLC (AIM:FUM) MED3000 Collaboration in EEA, UK & Switzerland
Futura Announces Collaboration with Cooper Consumer Health to Commercialise MED3000 in EEA, United Kingdom and Switzerland
Blockchain technology in the COVID-19 era
Blockchain technology is no longer constrained to the crypto ecosystem, as study has shown its potential for involvement in the healthcare industry.